Back to Results
First PageMeta Content
Business / Revenue recognition / Deferral / Financial ratio / Fixed asset / Financial statement / Net profit / Working capital / Income tax in the United States / Accountancy / Generally Accepted Accounting Principles / Finance


FOR IMMEDIATE RELEASE IMMUNOTEC ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS - Q2 year-to-date revenues increase by 11% VAUDREUIL-DORION, QC, 14 JuneImmunotec Inc. (TSX Venture Exchange: IMM), a Canadian base
Add to Reading List

Document Date: 2013-07-08 13:23:45

Open Document

File Size: 104,58 KB

Share Result on Facebook

City

Montreal / VAUDREUIL-DORION / /

Company

Immunotec Inc. / TSX Venture Exchange / /

Continent

Europe / /

Country

Mexico / United States / Canada / /

Currency

USD / /

Event

Earnings Announcement / /

IndustryTerm

manufacturing facilities / /

Person

Charles L. Orr / Patrick Montpetit / /

/

Position

Chief Financial Officer / leader / Chief Executive Officer / /

ProvinceOrState

Quebec / /

Region

Caribbean / /

URL

www.sedar.com / www.immunotec.com / /

SocialTag